MedTrace Logo

Surfactant Protein D Levels in Covid-19 Infection: Case-Control Study

NCT04618861 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 127

Last updated 2020-11-06

No results posted yet for this study

Summary

This study aims to provide some insight into the variation of SD-D protein levels in patients with Covid-19 (-) pneumonia, Covid-19 (+) pneumonia, and CT negative Covid-19 infection in comparison to the normal population through a larger number of cases. Objective of the study is to determine the serum surfactant protein D (SP-D) levels in Covid-19 pneumonia infection.

Conditions

  • Covid19
  • Pneumonia
  • Surfactant Protein Deficiency

Sponsors & Collaborators

  • Kafkas University

    lead OTHER

Eligibility

Min Age
18 Years
Sex
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-10-13
Primary Completion
2020-11-02
Completion
2020-11-02

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04618861 on ClinicalTrials.gov